Imaxio Acquires Orphan Drug Indicated for a Congenital Metabolic Disease

News   Jan 22, 2013

 
Imaxio Acquires Orphan Drug Indicated for a Congenital Metabolic Disease
 
 
 

RELATED ARTICLES

Nobel Prize for Chemistry 2017 Honors a Cool Revolution in Biochemistry

News

Cryo-EM allows the study of biomolecules at atomic resolution prepared under cryogenic conditions.

READ MORE

Funding Approved to Further Metabolomics Research

News

The NIH Common Fund Metabolomics Program has been approved for a second stage of support from fiscal years 2018-2021.

READ MORE

Two Studies Provide Significant Hope in the Fight Against Antibiotic Resistance

News

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE